Literature DB >> 31816036

Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial.

Mitchell S Cairo1,2,3,4,5, Julie-An Talano6, Theodore B Moore7, Qiuhu Shi8, Rona Singer Weinberg9, Brenda Grossman10, Shalini Shenoy11.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31816036      PMCID： PMC6902105          DOI： 10.1001/jamapediatrics.2019.4715

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN： 2168-6203            Impact factor:   16.193


× No keyword cloud information.
  6 in total

1.  T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients.

Authors:  Mark B Geyer; Angela M Ricci; Judith S Jacobson; Robbie Majzner; Deirdre Duffy; Carmella Van de Ven; Janet Ayello; Monica Bhatia; James H Garvin; Diane George; Prakash Satwani; Lauren Harrison; Erin Morris; Mildred Semidei-Pomales; Joseph Schwartz; Bachir Alobeid; Lee Ann Baxter-Lowe; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2012-02-08       Impact factor: 6.998

Review 2.  Cardiovascular complications and risk of death in sickle-cell disease.

Authors:  Mark T Gladwin
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

3.  A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Authors:  Shalini Shenoy; Mary Eapen; Julie A Panepinto; Brent R Logan; Juan Wu; Allistair Abraham; Joel Brochstein; Sonali Chaudhury; Kamar Godder; Ann E Haight; Kimberly A Kasow; Kathryn Leung; Martin Andreansky; Monica Bhatia; Jignesh Dalal; Hilary Haines; Jennifer Jaroscak; Hillard M Lazarus; John E Levine; Lakshmanan Krishnamurti; David Margolis; Gail C Megason; Lolie C Yu; Michael A Pulsipher; Iris Gersten; Nancy DiFronzo; Mary M Horowitz; Mark C Walters; Naynesh Kamani
Journal:  Blood       Date:  2016-09-13       Impact factor: 22.113

4.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

5.  Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  Eliane Gluckman; Barbara Cappelli; Francoise Bernaudin; Myriam Labopin; Fernanda Volt; Jeanette Carreras; Belinda Pinto Simões; Alina Ferster; Sophie Dupont; Josu de la Fuente; Jean-Hugues Dalle; Marco Zecca; Mark C Walters; Lakshmanan Krishnamurti; Monica Bhatia; Kathryn Leung; Gregory Yanik; Joanne Kurtzberg; Nathalie Dhedin; Mathieu Kuentz; Gerard Michel; Jane Apperley; Patrick Lutz; Bénédicte Neven; Yves Bertrand; Jean Pierre Vannier; Mouhab Ayas; Marina Cavazzana; Susanne Matthes-Martin; Vanderson Rocha; Hanadi Elayoubi; Chantal Kenzey; Peter Bader; Franco Locatelli; Annalisa Ruggeri; Mary Eapen
Journal:  Blood       Date:  2016-12-13       Impact factor: 22.113

Review 6.  Hematopoietic stem cell transplantation for sickle cell disease: state of the science.

Authors:  Julie-An Talano; Mitchell S Cairo
Journal:  Eur J Haematol       Date:  2014-10-10       Impact factor: 2.997
  6 in total
  4 in total

1.  Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.

Authors:  Deborah Friedman; Allen J Dozor; Jordan Milner; Marise D'Souza; Julie-An Talano; Theodore B Moore; Shalini Shenoy; Qiuhu Shi; Mark C Walters; Elliott Vichinsky; Susan K Parsons; Suzanne Braniecki; Chitti R Moorthy; Janet Ayello; Allyson Flower; Erin Morris; Harshini Mahanti; Sandra Fabricatore; Liana Klejmont; Carmella van de Ven; Lee Ann Baxter-Lowe; Mitchell S Cairo
Journal:  Bone Marrow Transplant       Date:  2021-05-06       Impact factor: 5.483

2.  Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.

Authors:  Mohsen Alzahrani; Moussab Damlaj; Neal Jeffries; Bader Alahmari; Avani Singh; Damiano Rondelli; John F Tisdale; Santosh L Saraf; Matthew M Hsieh
Journal:  Br J Haematol       Date:  2021-02-03       Impact factor: 8.615

3.  Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.

Authors:  Lakshmanan Krishnamurti; Staci D Arnold; Ann Haight; Allistair Abraham; Gregory Mt Guilcher; Tami John; Nitya Bakshi; Shalini Shenoy; Karen Syrjala; Paul L Martin; Sonali Chaudhury; Gretchen Eames; Olusola Festus Olowoselu; Matthew Hsieh; Josu De La Fuente; Kimberly A Kasow; Elizabeth Stenger; Anne Mertens; Fuad El-Rassi; Peter Lane; Bronwen E Shaw; Lillian Meacham; David Archer
Journal:  JMIR Res Protoc       Date:  2022-07-06

4.  Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.

Authors:  Adetola A Kassim; Alexis Leonard
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.